Investors

Welcome to the Mendus investor page. Mendus is listed on NASDAQ Stockholm under the ticker symbol IMMU.
Letter from the CEO
“A strong foundation for expanded clinical development”
To read the latest CEO comment, please click here.
Contact
Telephone
+46 (0)8 732 8400
info@mendus.com

Head Office
Västra Trädgårdsgatan 15
111 53 Stockholm
Sweden

R&D Offices
Emmy Noetherweg 2K
2333 BK Leiden
The Netherlands

